| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 437.6K | $6.44M | - | |
| Dir | 416.5K | $6.13M | - | |
| VP | 347.7K | $5.12M | - | |
| Other | 174.5K | $2.57M | - | |
| Other | 163.8K | $2.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 8, 2019 | Doyle William F53 | Executive Chairman | Sale+OE | 64,316 | $47.60 | $3,061,143.24 | -3.6% | |
| May 6, 2019 | Doyle William F53 | Executive Chairman | Sale+OE | 29,038 | $48.07 | $1,395,914.74 | -3.4% | |
| May 3, 2019 | Doyle William F53 | Executive Chairman | Sale+OE | 29,966 | $45.21 | $1,354,643.00 | -3.7% | |
| May 2, 2019 | Shah Pritesh75 | Chief Commercial Officer | Sale+OE | 1,204 | $43.80 | $52,729.18 | -1.5% | |
| Apr 10, 2019 | Leung Gabriel78 | Director | Sale+OE | 5,000 | $45.95 | $229,750.00 | -7.7% | |
| Apr 2, 2019 | Ambrogi Michael J. | Chief Operating Officer | Sale+OE | 49,891 | $47.34 | $2,362,053.02 | -4.3% | |
| Mar 11, 2019 | Leung Gabriel78 | Director | Sale+OE | 5,000 | $48.31 | $241,550.00 | -7.7% | |
| Mar 5, 2019 | Groenhuysen Wilhelmus Cm65 | Chief Financial Officer | Sale+OE | 90,000 | $53.94 | $4,854,311.55 | -11.0% | |
| Mar 4, 2019 | Danziger Asaf61 | Chief Executive Officer | Sale+OE | 16,268 | $55.89 | $909,286.05 | -2.2% | |
| Mar 1, 2019 | Leung Gabriel78 | Director | Sale+OE | 25,000 | $55.01 | $1,375,275.00 | -29.4% |